Screening: Biology dictates the fate of young women with breast cancer

Nature Reviews Clinical Oncology

Volumn 10, Issue 12, 2013, Pages 673-675

  Eklund, Martin ^a   Esserman, Laura J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE CONTROL; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MOLECULAR BIOLOGY; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; YOUNG ADULT;

BIOLOGICAL FACTORS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY;

EID: 84889584486     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2013.196     Document Type: Article

References (10)

1. Webb, M. L. et al. A failure analysis of invasive breast cancer: Most deaths from disease occur in women not regularly screened. Cancer http://dx.doi.org/10.1002/cncr.28199.
2. Slamon, D. J. et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER 2/neu oncogene. Science 235, 177-182 (1987).
3. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869-10874 (2001).
4. van't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
5. Michaelson, J. et al. The pattern of breast cancer screening utilization and its consequences. Cancer 94, 37-43 (2002).
6. Lin, C. et al. Locally advanced breast cancers are more likely to present as interval cancers: Results from the I SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res. Treat. 132, 871-879 (2012).
7. Esserman, L. J., Thompson, I. M. Jr & Reid, B. Overdiagnosis and overtreatment in cancer: An opportunity for improvement. JAMA 310, 797-798 (2013).
8. Barker, A. D. et al. I SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin. Pharmacol. Ther. 86, 97-100 (2009).
9. Esserman, L. J. et al. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res. Treat. 130, 725-734 (2011).
10. Michailidou, K. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353-361 (2013).